News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
68,650 Results
Type
Article (1921)
Company Profile (2)
Press Release (66727)
Section
Business (21462)
Career Advice (9)
Deals (4552)
Drug Development (8162)
FDA (1804)
Job Trends (802)
News (37015)
Policy (3560)
Tag
Academia (93)
Alliances (8079)
Alzheimer's disease (113)
Approvals (1807)
Artificial intelligence (5)
Bankruptcy (8)
Best Places to Work (574)
Biosimilars (9)
Biotechnology (5)
Breast cancer (9)
Cancer (88)
Career advice (9)
Cell therapy (11)
Clinical research (6838)
Collaboration (27)
Compensation (4)
COVID-19 (180)
C-suite (5)
Data (81)
Diabetes (6)
Diagnostics (581)
Drug discovery (7)
Duchenne muscular dystrophy (6)
Earnings (7425)
Events (6786)
Executive appointments (15)
FDA (1859)
Funding (23)
Gene therapy (5)
GLP-1 (35)
Government (233)
Healthcare (1070)
Infectious disease (183)
Inflammatory bowel disease (12)
IPO (1598)
Job creations (240)
Job search strategy (9)
Layoffs (6)
Legal (942)
Liver cancer (14)
Lung cancer (17)
Lymphoma (4)
Manufacturing (12)
Medical device (1102)
Medtech (1103)
Mergers & acquisitions (2984)
Metabolic disorders (19)
Neuroscience (132)
NextGen Class of 2024 (220)
Non-profit (61)
Northern California (79)
Obesity (9)
Parkinson's disease (8)
Patents (8)
People (4889)
Phase I (1853)
Phase II (2851)
Phase III (2607)
Pipeline (29)
Postmarket research (241)
Preclinical (646)
Radiopharmaceuticals (21)
Rare diseases (11)
Real estate (598)
Regulatory (2501)
Reports (6)
Research institute (93)
Schizophrenia (4)
Series A (6)
Southern California (56)
Startups (421)
Supply chain (4)
United States (619)
Vaccines (14)
Date
Today (10)
Last 7 days (63)
Last 30 days (230)
Last 365 days (3387)
2024 (2812)
2023 (3815)
2022 (7015)
2021 (6374)
2020 (5874)
2019 (3863)
2018 (3010)
2017 (3561)
2016 (3171)
2015 (4030)
2014 (3020)
2013 (2600)
2012 (2775)
2011 (2902)
2010 (2663)
Location
Africa (79)
Asia (21034)
Australia (2408)
California (153)
Canada (136)
China (60)
Connecticut (6)
Europe (12192)
Florida (6)
Illinois (7)
India (4)
Japan (21)
Kansas (5)
Maryland (52)
Massachusetts (127)
Minnesota (18)
New Jersey (72)
New York (70)
North Carolina (43)
Northern California (79)
Pennsylvania (21)
South America (105)
Southern California (56)
Texas (7)
Utah (6)
Virginia (6)
68,650 Results for "biosight ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Ayala Pharmaceuticals Announces Closing of Merger with Biosight
Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, announced the closing of its merger with Biosight, Ltd., pursuant to which Ayala acquired Biosight.
October 19, 2023
·
6 min read
Deals
Ayala Pharmaceuticals and Biosight Enter into Definitive Merger Agreement
Ayala Pharmaceuticals, Inc. and Biosight Ltd. today announced they have entered into a definitive merger agreement pursuant to which Ayala will combine with Biosight in an all-stock transaction.
July 27, 2023
·
11 min read
Press Releases
ReWalk Robotics Ltd. Finalizes Corporate Name Change to Lifeward Ltd.
September 12, 2024
·
4 min read
Press Releases
NLS Pharmaceutics Ltd. Regains Full Compliance with Nasdaq Listing Requirements
October 28, 2024
·
1 min read
Press Releases
Matricelf Ltd. Announces Significant Milestones in Spinal Cord Injury Treatment Development
October 28, 2024
·
1 min read
Press Releases
SEED Therapeutics Appoints Eisai Co., Ltd.’s Dr. Yoshiharu Mizui to Board of Directors
September 12, 2024
·
2 min read
Business
Mid-Atlantic BioTherapeutics, Inc. and SMITM Capital Markets Ltd enter into a significant financing agreement
SMITM CAPITAL MARKETS LTD, has announced a significant agreement with Mid-Atlantic BioTherapeutics, Inc. (MABT), a clinical-stage ready US biopharmaceutical company.
June 19, 2024
·
4 min read
Deals
Specac, Ltd Acquires Harrick Scientific
Specac, Ltd announced today the acquisition of Harrick Scientific, Inc.
April 2, 2024
·
3 min read
Drug Development
Biosight Launches a Phase 1/2 Clinical Trial of Aspacytarabine in Combination with Venetoclax for First-Line AML Induction Therapy, Followed by Aspacytarabine Consolidation
Biosight Ltd today announced enrollment of a first patient to a phase 1/2 clinical trial designed to evaluate the safety and efficacy of its lead asset aspacytarabine (BST-236) in combination with the BCL2 inhibitor venetoclax for induction therapy of newly-diagnosed Acute Myeloid Leukemia (AML), followed by aspacytarabine single-agent consolidation therapy.
November 22, 2022
·
3 min read
Bioretec Ltd’s business review January-March 2024: Controlled launch in the U.S. progresses
This announcement summarizes Bioretec Ltd’s business review for January-March 2024.
May 16, 2024
·
6 min read
1 of 6,865
Next
